Apollon Financial’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.12M Buy
8,584
+1
+0% +$129 0.13% 136
2026
Q2
$1.05M Sell
8,583
-510
-6% -$58.5K 0.12% 137
2026
Q1
$998K Sell
9,093
-200
-2% -$22.7K 0.14% 126
2025
Q4
$1.06M Sell
9,293
-260
-3% -$29.5K 0.15% 113
2025
Q3
$1.05M Sell
9,553
-1,342
-12% -$141K 0.17% 104
2025
Q2
$1.13M Sell
10,895
-245
-2% -$24.6K 0.24% 93
2025
Q1
$1.15M Sell
11,140
-1,035
-9% -$111K 0.27% 85
2024
Q4
$1.27M Sell
12,175
-895
-7% -$97.2K 0.31% 72
2024
Q3
$1.46M Sell
13,070
-630
-5% -$69K 0.43% 52
2024
Q2
$1.43M Sell
13,700
-505
-4% -$53K 0.46% 46
2024
Q1
$1.56M Sell
14,205
-250
-2% -$26.4K 0.54% 40
2023
Q4
$1.5M Buy
+14,455
New +$1.39M 0.59% 38

Other funds holding FXH

Apollon Financial's FXH Position: Q3 2026 in Review

Apollon Financial increased its First Trust Health Care AlphaDEX Fund (FXH) stake by 0.01% in Q3 2026, buying an estimated $129 and bringing the position to 8,584 shares worth $1.12M. The position accounts for 0.13% of the portfolio, ranked #136.

Apollon Financial first reported a position in FXH in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.56M in Q1 2024. 267 funds tracked by Wall St. Rank hold FXH as of Q3 2026.

  • Apollon Financial held 8,584 shares of First Trust Health Care AlphaDEX Fund worth $1.12M as of Q3 2026.
  • Apollon Financial bought 1 First Trust Health Care AlphaDEX Fund share in Q3 2026, an estimated $129.
  • First Trust Health Care AlphaDEX Fund made up 0.13% of Apollon Financial's portfolio in Q3 2026, its #136 holding.
  • Apollon Financial first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2023 and has held it in 12 quarters since.
  • Apollon Financial's First Trust Health Care AlphaDEX Fund position peaked at $1.56M in Q1 2024.
  • 267 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q3 2026.

Based on Apollon Financial's 13F filing for Q3 2026, filed 23 Oct 2026.